In the last trading session, 1.28 million Solid Biosciences Inc (NASDAQ:SLDB) shares changed hands as the company’s beta touched 2.02. With the company’s per share price at $5.58 changed hands at -$0.2 or -3.46% during last session, the market valuation stood at $425.86M. SLDB’s last price was a discount, traded about -169.71% off its 52-week high of $15.05. The share price had its 52-week low at $2.88, which suggests the last value was 48.39% up since then.
Analysts gave the Solid Biosciences Inc (SLDB) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.08. If we narrow down to specifics, the data shows that 0 out of 6 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SLDB as a Hold, 6 felt it is a Buy and 0 rated the stock as Underweight.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Instantly SLDB was in red as seen at the end of in last trading. With action 38.46%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 39.50%, with the 5-day performance at 38.46% in the green. However, in the 30-day time frame, Solid Biosciences Inc (NASDAQ:SLDB) is 86.00% up.
The consensus price target for the stock as assigned by Wall Street analysts is 19, meaning bulls need an upside of 70.63% from its current market value. According to analyst projections, SLDB’s forecast low is 12 with 20 as the target high. To hit the forecast high, the stock’s price needs a -258.42% plunge from its current level, while the stock would need to soar -115.05% for it to hit the projected low.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 32.21%. The 2025 estimates are for Solid Biosciences Inc earnings to increase by 39.19%, but the outlook for the next 5-year period is at 19.61% per year.
SLDB Dividends
Solid Biosciences Inc is expected to release its next quarterly earnings report in March.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF . With 854.68 shares estimated at $4.77 million under it, the former controlled 1.12% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 0.85% of the shares, roughly 650.02 shares worth around $3.63 million.
